FDA Drug/Biologics Approval BLA 125085 S-331, BEVACIZUMAB

FDA Drug/Biologics Approval BLA 125085 S-331, BEVACIZUMAB

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125085 S-331
Company: GENENTECH
Drug Name: AVASTIN
Active Ingredients: BEVACIZUMAB
Strength: 400MG
Dosage Form/Route: VIAL; INTRAVENOUS
Action Date: 02/26/2004
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details